Emerging infectious agents: Do they pose a risk to the safety of transfused blood and blood products?

Clinical Infectious Diseases

Volumn 34, Issue 6, 2002, Pages 797-805

  Chamberland, Mary E ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOLOGICAL WARFARE; BLOOD TRANSFUSION; BRAIN SPONGIOSIS; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MEDICAL DECISION MAKING; NONHUMAN; POSTTRANSFUSION HEPATITIS; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SAFETY; STORAGE; TICK BORNE ENCEPHALITIS; UNITED STATES;

BLOOD; BLOOD TRANSFUSION; HEPACIVIRUS; HEPATITIS B VIRUS; HIV; HUMANS; PRION DISEASES; RISK ASSESSMENT; TERRORISM; TICK-BORNE DISEASES; TRAVEL;

EID: 0037087046     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/338787     Document Type: Article

References (71)

1. Posttransfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors
2. Monetary compensation for plasma donors: A record of safety
3. Oversight and monitoring of blood safety in the United States
4. Transfusion medicine: First of two parts - Blood transfusion
5. Canadian animal handlers infected with animal simian foamy virus: Cautioned against blood donation
6. Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection
7. Transfusion safety when you don't know what you are looking for: Issues related to emerging pathogens
8. Risk of human immunodeficiency virus (HIV) transmission by blood transfusions before the implementation of HIV-1 antibody screening
9. Research opportunities in transfusion medicine
10. The risks of transfusion-transmitted infection: Direct estimation and mathematical modeling
11. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996
12. NAT of the United States and Canadian blood supply
13. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases: Report of the Interorganizational Task Force on nucleic acid amplification testing of blood donors
14. Closing the windows on viral transmission by blood transfusion
15. The risk of transfusion-transmitted viral infections
16. Residual risk of transfusion-associated hepatitis
17. Non-A, non-B hepatitis unrelated to the hepatitis C virus (non-ABC)
18. Acute non-A - E hepatitis in the United States and the role of hepatitis G virus infection
19. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease
20. G-pers creepers, where'd you get those papers? A reassessment of the literature on hepatitis G virus
21. Transfusion-associated TT virus infection and its relationship to liver disease
22. SEN virus infection and its relationship to transfusion-associated hepatitis
23. The presence of a newly identified infectious agent (SEN virus) in patients with liver diseases and in blood donors in Japan
24. Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies
25. Transmissible spongiform encephalopathies in humans
26. Blood infectivity and the prospects for a diagnostic screening test in Creutzfeldt-Jakob disease
27. Transfusion medicine and spongiform encephalopathy
28. Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans
29. The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy
30. Risk factors for Creutzfeldt-Jakob disease: A reanalysis of case control studies
31. Creutzfeldt-Jakob disease and blood transfusion
32. Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95
33. Surveillance for Creutzfeldt-Jakob disease among persons with hemophilia
34. New variant Creutzfeldt-Jakob disease and bovine spongiform encephalopathy
35. Creutzfeldt-Jakob disease in the United States, 1979-1994: Using national mortality data to assess the possible occurrence of variant cases
36. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples
37. Transmission of BSE by blood transfusion in sheep
38. Adaptation of the bovine spongiform encephalopathy agent to primates and comparison with Creutzfeldt-Jakob disease: Implications for human health
39. Transfusion-transmitted malaria in the United States from 1963 through 1999
40. Tryspanosoma cruzi, the etiologic agent of Chagas' disease: Status in the blood supply in endemic and nonendemic countries
41. Use of polymerase chain reaction to diagnose the fifth reported US case of autochthonous transmission of Trypanosoma cruzi, in Tennessee, 1998
42. Parasites and other emergent infectious agents
43. Transfusion-transmitted babesiosis in Washington state: First reported case caused by a WA1-type parasite
44. Rocky Mountain spotted fever caused by blood transfusion
45. Human granulocytic ehrlichiosis after red cell transfusion
46. Transmission of tick-borne agents of disease by blood transfusion: A review of known and potential risks in the United States
47. Acute blood donor co-infection with Babesia microti (Bm) and Borrleia burgdorferi (Bb)
48. Evidence for transmission of Babesia microti from Connecticut blood donors to recipients
49. Transfusion-associated transmission of babesiosis in New York State
50. Persistent parasitemia after acute babesiosis
51. Single-donor platelets reduce the risk of septic platelet transfusion reactions
52. Transfusion-associated bacterial sepsis
53. Adverse consequences of blood transfusion: Quantitative risk estimates
54. Bacterial contamination of platelets at a university hospital: Increased identification due to intensified surveillance
55. Transfusion-transmitted bacterial infections in the United States, 1998-2000
56. Evaluation of donor skin disinfection methods
57. Diversion of initial blood flow to prevent whole-blood contamination by skin surface bacteria: An in vitro model
58. Viral inactivation
59. America's Blood Centers and the gift relationship
60. Safety of blood donations following a natural disaster
61. Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001